A Study on the Safety and Effectiveness of IBI318 Combined With Conventional TACE (cTACE) as a Perioperative Treatment for Potentially Resected Hepatocellular Carcinoma
Clinical trial NCT04635527 · TERMINATED
Trial details
- NCT number
- NCT04635527
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-24
- Primary completion
- 2021-08-27
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.